Literature DB >> 26759304

Aspergillus fumigatus promotes T helper type 2 responses through thymic stromal lymphopoietin production by human corneal epithelial cells.

Luping Wang1, Leyi Wang1, Xinyi Wu1.   

Abstract

BACKGROUND: Fungal keratitis is a major cause of blindness. To understand the mechanism of both innate and adaptive immunity in corneal infection is of great significance in the treatment and prevention of fungal keratitis. Our previous study concerned innate immunity. Here, we explored the potential role of thymic stromal lymphopoietin (TSLP) in adaptive immunity of fungal keratitis.
METHODS: Human corneal epithelial cells (HCECs) were stimulated with Aspergillus fumigatus hyphae (10(6) pieces per millilitre) with or without TSLP siRNA, and peripheral blood mononuclear cells (PBMCs) were cultured with or without TSLP. HCECs and PBMCs were co-cultured in a transwell system for various periods. Then we collected PBMCs and detected the proliferation and activation as well as T helper type 2 (Th2) differentiation by flow cytometry and quantitative real-time reverse transcription polymerase chain reaction. IgG and IgA levels in supernatants of PBMCs were measured by means of ELISA.
RESULTS: Thymic stromal lymphopoietin could induce a Th2 response in vitro, and the expression of TSLP was highly increased in HCECs stimulated with A. fumigatus hyphae. A. fumigatus-infected HCECs were capable of promoting human lymphocyte proliferation and activating human CD4(+) T cells, CD8(+) T cells and B cells by up-regulating the expression of activation marker CD69. Importantly, Th2 differentiation of CD4(+) T cells was induced during co-culture with A. fumigatus-infected HCECs in a transwell system. Interestingly, blockade of TSLP using siRNA prevented the proliferation and activation of lymphocytes as well as Th2 differentiation. We also detected an increased IgG level that was associated with TSLP.
CONCLUSION: These findings suggested that HCEC-derived TSLP has a key role in adaptive immune responses of fungal keratitis via skewing Th2 differentiation and promoting humoral immunity.
© 2016 Royal Australian and New Zealand College of Ophthalmologists.

Entities:  

Keywords:  Aspergillus fumigatus; Th2 response; adaptive immunity; human corneal epithelial cell; thymic stromal lymphopoietin

Mesh:

Substances:

Year:  2016        PMID: 26759304     DOI: 10.1111/ceo.12706

Source DB:  PubMed          Journal:  Clin Exp Ophthalmol        ISSN: 1442-6404            Impact factor:   4.207


  6 in total

Review 1.  Review of clinical and basic approaches of fungal keratitis.

Authors:  Jie Wu; Wen-Song Zhang; Jing Zhao; Hong-Yan Zhou
Journal:  Int J Ophthalmol       Date:  2016-11-18       Impact factor: 1.779

Review 2.  Immunologic mechanism of fungal keratitis.

Authors:  Rui-Bo Yang; Li-Ping Wu; Xiao-Xiao Lu; Chen Zhang; Hui Liu; Yue Huang; Zhe Jia; Yi-Chen Gao; Shao-Zhen Zhao
Journal:  Int J Ophthalmol       Date:  2021-07-18       Impact factor: 1.779

3.  TSLP Protects Corneas From Pseudomonas aeruginosa Infection by Regulating Dendritic Cells and IL-23-IL-17 Pathway.

Authors:  Xinhan Cui; Nan Gao; Rao Me; Jianjiang Xu; Fu-Shin X Yu
Journal:  Invest Ophthalmol Vis Sci       Date:  2018-08-01       Impact factor: 4.799

4.  TSLP Produced by Aspergillus fumigatus-Stimulated DCs Promotes a Th17 Response Through the JAK/STAT Signaling Pathway in Fungal Keratitis.

Authors:  Fang Han; Hui Guo; Leyi Wang; Yuting Zhang; Lin Sun; Chenyang Dai; Xinyi Wu
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-12-01       Impact factor: 4.799

Review 5.  Recent advances in diagnosis and management of Mycotic Keratitis.

Authors:  Prafulla K Maharana; Namrata Sharma; Ritu Nagpal; Vishal Jhanji; Sujata Das; Rasik B Vajpayee
Journal:  Indian J Ophthalmol       Date:  2016-05       Impact factor: 1.848

6.  Ribonuclease T2 from Aspergillus fumigatus promotes T helper type 2 responses through M2 polarization of macrophages.

Authors:  Jia-Jie Chen; Yong-Shen He; Xiao-Jun Zhong; Ze-Lang Cai; Yan-Si Lyu; Zhen-Fu Zhao; Kunmei Ji
Journal:  Int J Mol Med       Date:  2020-05-21       Impact factor: 4.101

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.